|
|
 |
|
Viewing report
|
|
|
|
Research Report on Anti-HBV Drug Market
Sunfaith China Ltd, July 2009, Pages: 8
Under the joint impact of four anti-HBV nucleoside drugs, i.e. lamivudine, adefovir dipivoxil, entecavir and Telbivudine, from 2001~2006, the anti-HBV market of China’s sample hospitals in key cities grew at a speed of 30%, which was more than average. It is no doubt that China’s anti-HBV drug will continue to develop rapidly in the future. This report mainly classifies the current anti-HBV drugs, and analyzes the most important types of anti-HBV drug markets and demand markets.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Research Report on China's Anti-HBV Drug Market
Research Report on Chinese Anti Senile Dementia Drug Market, 2010-2011
Chinese Markets for Brain Cancer Treatment Drugs
Chinese Markets for Kidney Cancer Treatment Drugs
Chinese Markets for Anti-Obesity Drugs
Chinese Markets for Lymphoma Treatment Drugs
Chinese Markets for Cancer Treatment Drugs
Chinese Markets for Leukemia Treatment Drugs
Research Report on Chinese Anti-Tumor Drug Market, 2009
Chinese Markets for Anti-Tumor Drugs
|
|
|
|
